In obese mice, injecting apolipoprotein A-IV leads to a 220% increase in insulin release and a 140% increase in C-peptide during a glucose tolerance test, suggesting a direct enhancement of insulin production by pancreatic beta cells.

44

Pro

0

Against

Evidence from Studies

Supporting (1)

44

Community contributions welcome

44

Apolipoprotein A-IV is induced by high-fat diets and mediates positive effects on glucose and lipid metabolism

Randomized Controlled Trial

Human & Animal & In Vitro

2025 May

Scientists gave a protein called apoA-IV to obese mice and found it helped their pancreas release more insulin when blood sugar went up, which is exactly what the claim says. This means the protein helps the body better control blood sugar after eating.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Apolipoprotein A-IV is induced by high-fat diets and mediates positive effects on glucose and lipid metabolism

Score: 44

DOI: 10.1016/j.molmet.2025.102119

Similar Assertions

In obese mice, injecting apolipoprotein A-IV changes the levels of certain liver proteins involved in lipid transport, increasing those that help clear lipoproteins and decreasing those linked to artery disease, which may improve how the body processes fats.

44

0

76%

In obese mice, a single injection of a specific human protein called apolipoprotein A-IV lowers blood sugar levels by about half within two hours by enhancing glucose uptake in fat tissues and decreasing glucose output from the liver, without involving insulin.

44

0

75%